Literature DB >> 7962348

Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function.

J A Gonzalez-Hernandez1, S R Bornstein, M Ehrhart-Bornstein, E Späth-Schwalbe, G Jirikowski, W A Scherbaum.   

Abstract

Interleukin-6 (IL-6) is an important mediator in the interaction of the hypothalamo-pituitary-adrenal axis with the immune system. Recently, a direct influence of IL-6 on adrenal steroidogenesis has been demonstrated. Therefore, we designed a study to determine whether IL-6 is expressed within the normal human adrenal gland. The combination of in situ hybridization and specific immunostaining was eminently suited to identify the cell types producing IL-6. IL-6 messenger ribonucleic acid occurred in the inner zone of the adrenal cortex in anti-17 alpha-hydroxylase-positive steroid cells. Also, CD68-positive macrophages in the zona reticularis showed a positive signal. No reaction was seen in chromaffin cells. We conclude that under normal conditions, IL-6 is expressed in specialized adrenocortical cells. Therefore, IL-6 may play an important role as a paracrine or autocrine factor in a local immune-adrenal interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962348     DOI: 10.1210/jcem.79.5.7962348

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Cytokine interactions with adrenal medullary chromaffin cells.

Authors:  Shirley A Douglas; Dharshini Sreenivasan; Fiona H Carman; Stephen J Bunn
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

2.  Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids.

Authors:  P O Cover; D Slater; J C Buckingham
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 3.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Serotonin increases interleukin-6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro.

Authors:  P K Ritchie; H H Knight; M Ashby; A M Judd
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

5.  Tumor necrosis factor increases interleukin-6 release from adrenal zona glomerulosa cellsin vitro.

Authors:  A M Judd; P K Ritchie
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

6.  Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands.

Authors:  George Kontogeorgos; Irene Messini; Efi Kyrodimou; Linda Giannikaki; Emmanuel Zois; George Koukoulis; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.633

7.  Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice.

Authors:  J Raber; R D O'Shea; F E Bloom; I L Campbell
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

8.  Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.

Authors:  Jan Komorowski; Jolanta Jurczynska; Tomasz Stepien; Krzysztof Kolomecki; Krzysztof Kuzdak; Henryk Stepien
Journal:  Int J Mol Sci       Date:  2010-05-26       Impact factor: 5.923

Review 9.  Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature.

Authors:  T Akatsu; K Kameyama; K Araki; T Ashizawa; G Wakabayashi; M Kitajima
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

10.  Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress.

Authors:  Milena Girotti; Jennifer J Donegan; David A Morilak
Journal:  Psychoneuroendocrinology       Date:  2012-12-04       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.